Langasog, Fe L.

HRN: 18-87-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/07/2026
07/13/2026
IV
4.5 G IV LD Then 2.25 G IV
Q6
CAP WITH HAP COMPONENT
Checking Initial Appropriateness 
07/08/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2026
07/14/2026
IV
2.25gm
Q6
CAP
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: